Stop the presses, folks. The United States Senate, a body that normally can't agree on what day of the week it is, unanimously passed a bill on Tuesday. Yes, every single senator said "sure, why not" to S. 494, the National Plan for Epilepsy Act. As Conservative Brief reported, the bipartisan legislation sailed through without a single objection, which honestly feels like witnessing a solar eclipse during a blue moon.
The bill was introduced by Sen. Eric Schmitt, a Republican from Missouri, and it tells the Department of Health and Human Services to come up with an actual coordinated game plan for preventing, diagnosing, treating, and eventually curing epilepsy. Revolutionary concept, right? Getting the government to coordinate on something?
Here's the thing that makes this less funny and more genuinely important: epilepsy impacts close to 3 million grown adults and over 450,000 kids across this country. One out of every 26 people will end up developing it at some point. The condition causes unprovoked, recurring seizures and significantly raises the risk of dying early, particularly for patients whose seizures remain uncontrolled. Oh, and it costs more than $54 billion per year in healthcare expenses. That's billion with a B.
Schmitt co-founded the Senate Epilepsy Caucus and has a deeply personal connection to this fight because his own son lives with the condition. So credit where it's due, the guy actually cares about this one.
Sen. Amy Klobuchar, a Democrat from Minnesota, co-sponsored the legislation and pointed out that over 55,000 people in her state alone deal with epilepsy. So there you have it, a Republican and a Democrat walking into a Senate chamber and actually accomplishing something together. Truly the buddy cop movie nobody expected.
The bill requires HHS to coordinate research across multiple federal agencies, including the NIH, CDC, FDA, the Department of Defense, and the VA. It also creates an Advisory Council on Epilepsy Research, Care, and Services that will include everyone from federal experts to patients to nonprofit representatives. They'll evaluate what the government is doing and report back every two years.
Key priorities include better patient outcomes, faster innovation toward treatments and cures, improved data systems, reducing stigma, cutting deaths related to Sudden Unexpected Death in Epilepsy, and expanding access to specialized care.
Now here's the part that fiscal hawks will appreciate: everything in this bill has an expiration date of December 31, 2035. That's right, Congress actually built in a self-destruct mechanism to prevent permanent bureaucratic bloat. The approach follows the template of the National Plan to End Parkinson's Act without spawning new entitlement programs or agencies that live forever like governmental cockroaches.
Epilepsy advocacy organizations celebrated the vote after years of pushing for exactly this kind of action. The legislation now heads over to the House, where companion bills already have bipartisan backing from the House Epilepsy Caucus. If it passes there too, the country would finally have a clear strategy against one of its most widespread yet chronically overlooked neurological disorders.
Bipartisanship. In this economy. What a time to be alive.
Like what you see? Then sign up for our Free Newsletter
